- Home
- Companies
- canada british columbia
- arthritis
Show results for
Refine by
Arthritis Suppliers In Canada British Columbia
5 companies found
based inVictoria, BRITISH COLUMBIA (CANADA)
Eupraxia Pharmaceuticals is a clinical-stage biotechnology company leveraging proprietary and innovative delivery technology with the goal of providing the right dose of drug in the right place for the right amount of time in indications with a high ...
Eupraxia’s lead product candidate, EP-104IAR, is designed to meet the significant unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis ...
based inVancouver, BRITISH COLUMBIA (CANADA)
STEMCELL Technologies provides high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources to scientists around the world working on stem cell, immunology, cancer, regenerative medicine, ...
Interleukin 2 (IL-2) is a monomeric cytokine that was originally identified as a T cell growth factor (Gaffen & Liu). It binds to heterotrimeric receptors consisting of CD25, CD122, and CD132. Upon binding, it activates JAK3-, STAT5-, and ...
based inSurrey, BRITISH COLUMBIA (CANADA)
BioInteractive Technologies, endorsed by the Mayo Clinic & Techstars, is a Medical Device and Digital Health company developing intelligent wearables for physical therapy, using its patent-pending TENZR musculoskeletal sensing ...
Personalized physical therapy combined with the patented TENZR Trainer & Tracker ensures accurate rehabilitation of the hand, wrist, and ...
based inSummerville, PRINCE EDWARD ISLAND (CANADA)
North American and European consumers are becoming more concerned with health: their own health as they (especially baby boomers) age and the health of future generations. As concerns about the impact of pollution on general health and the health of ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are ...